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ABSTRACT 
Objectives: The study compared nasopharyngeal carriage of 
resistant pneumoniae in human immunodeficiency virus (HIV)- 
seropositive and seronegative children. 
Methods: Nasopharyngeal colonization with Streptococcus 
pneumoniae was investigated during May 1996 in 162 HIV- 
negative infants and children (age range, 1-38 mo) and 40 HIV- 
infected children (age range, 39-106 mo) living in an orphanage 
in lasi, northeastern Romania. The HIV-infected children lived 
separated from the other children and were cared for by a dif- 
ferent staff. Streptococcus pneumoniae was isolated from 12 
of 40 (30%) HIV-infected and from 81 of 160 (50%) HIV-neg- 
ative children. Antimicrobial susceptibility to penicillin and cef- 
triaxone was determined by E-test, and to another five 
antibiotics by disk diffusion. Serotyping was performed by the 
Quellung method on 81 of 93 (87%) isolates. 
Results: Serotypes 6A, BB, 19A, and 23F together represented 
98% of all isolates. Ninety-nine percent of S. pneumoniae iso- 
lates were resistant to penicillin, and 74% were highly resistant 
to penicillin (minimum inhibitory concentration [MIC] > 1 pg/mL); 
MIC,, and MIC,, to penicillin of the isolates were 2 kg/mL and 
8 pg/mL, respectively. Eighty-nine of ninety-one isolates were 
susceptible to ceftriaxone; 99%, 87%, 87%, 48%, and 21% of 
the isolates were resistant to trimethoprim-sulphamethoxazole, 
erythromycin, clindamycin, tetracycline, and chloramphenicol, 
respectively. Eighty-two (89%) isolates were multidrug resistant 
(resistant to 23 antibiotic classes); 37 of 92 (40%) isolates were 
resistant to 5 or more antibiotic classes, and 16 of these 37 
(43%) belonged to serotype 19A. All serotype 19 isolates were 
highly resistant to penicillin. 
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Conclusions: No significant differences were observed in the 
resistance rates of S. pneumoniae in HIV-infected children com- 
pared to HIV-negative children. Multidrug-resistant pneumo- 
cocci were highly prevalent in this Romanian orphanage in both 
HIV-negative and older HIV-infected children. The observed 
high prevalence of multidrug-resistant pneumococci (coupled 
with high penicillin resistance) with a limited number of circu- 
lating serotypes emphasizes the need to further evaluate the 
conjugate vaccines in children at risk for invasive pneumococ- 
cal infection. 
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Streptococcus pneumoniae is an important cause of pedi- 
atric morbidity and mortality, and resistance of S. pneu- 
moniae to antimicrobial agents is increasing 
worldwide.‘,’ The main reservoir of S. pneumoniae is 
the nasopharynx. Infants and young children have the 
highest rates of nasopharyngeal colonization with Spneu- 
moniae, and colonization and infection with antibiotic- 
resistant S.pneumoniae (resistant S.pneumoniae) occur 
frequently3,* Risk factors for emergence of resistant S. 
pneumoniae include prior antibiotic treatment; day-care 
attendance, particularly in children younger than 2 years 
of age; recent hospitalizations; and recurrent infections.5-8 
Nasopharyngeal colonization with resistant S. pneumo- 
niae reaches 59% among children who attend day-care 
centers.9-11 Surveillance of antimicrobial susceptibility as 
well as serogroups of Spneumoniae carried in the upper 
respiratory tract may be considered a practical way of 
providing accurate information on the susceptibilty of 
the Xpneumoniae isolates causing disease.12J3 
Although resistant S. pneumoniae is an emerging 
problem worldwide, there is a marked geographic vari- 
ability in the levels of penicillin resistance.1-2 In Europe, 
a high prevalence of resistant S. pneumoniae has been 
reported in Spain, France, Greece, and eastern Europe.14-18 
The main purpose of this study was to obtain data 
on the prevalence and susceptibility patterns of Spneu- 
moniae in Romania, because few data are available from 
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this country in the English-language literature. The objec- 
tives of the present study were to study the nasopha- 
ryngeal colonization with S. pneumoniae in children 
cared for in an orphanage in Iasi, the capital town of 
northeastern Romania, and to compare the colonization 
rates of the HIV-infected children with those of the HIV- 
negative children. In addition, the prevalence and resis- 
tance patterns of Spneumoniae were documented, and 
the distribution of Spneumoniae serotypes in the insti- 
tution were determined. 
PATIENTS AND METHODS 
Patients 
The study was conducted in May 1996 in the orphanage 
(“Leaganul de copii”) of Iasi, the capital town of north- 
eastern Romania. All the HIV-negative healthy children 
younger than 3 years of age and all the HIV-infected chil- 
dren cared for at this orphanage were enrolled in the 
study. The HIV-infected children were hospitalized in a 
separate building in a different area of the city. Care for 
these children was provided by a different team. The HIV- 
negative children lived in a different building and were 
grouped according to their age in the three floors of the 
building. 
Human immunodeficiency virus-serologic status was 
established by an enzyme-linked immunosorbent assay 
(ELISA) test and, in some cases, by a positive Western 
blot test. All HIV-infected children were diagnosed as suf- 
fering from symptomatic HIV infection. None was receiv- 
ing anti-retroviral drugs at the time of the study. CD4 
T-lymphocyte counts were not obtained in the months 
preceding the nasopharyngeal sampling. 
Bacteriology 
Nasopharyngeal samples were obtained with transport 
swabs and placed in MW173 Amies medium (Transwab; 
Medical Wire and Equipment, Potley, UK). Swabs were 
transported via air to Israel and processed within 24 
hours at the Clinical Microbiology Laboratory, Soroka Uni- 
versity Medical Center. Swabs were plated on trypticase 
agar media containing 5% sheep blood agar and incu- 
bated aerobically at 35°C for 48 hours. Presumptive iden- 
tification of S.pneumoniae was based on the presence 
of alpha hemolysis and inhibition by optochin. Con- 
firmation was made by positive slide agglutination 
(Phadebact, Pharmacia Diagnostics, Uppsala, Sweden). 
Susceptibility to penicillin, erythromycin, clin- 
damycin, trimethoprim-sulphamethoxazole (TMP/SMX), 
tetracycline, and chloramphenicol was performed by the 
disk-diffusion method and interpreted according to the 
National Committee for Clinical Laboratory Standards 
(NCCLS).” Susceptibility to penicillin and ceftriaxone 
was performed by E-test (PDM Epsilometer, AB Biodisk, 
Solna, Sweden). Minimal inhibitory concentrations (MIC) 
falling between two marks on the E-test strip were 
rounded up to the next higher twofold dilution, as rec- 
ommended in the packet insert. Isolates with a MIC over 
0.125 kg/rnL but less than 1.0 kg/rnL were considered 
intermediately susceptible to penicillin and those with 
MIC over 1.0 Fg/mL were defined as resistant. Ceftri- 
axone resistance was defined as intermediate if MIC 
were between 0.5 and 1.0 pg/mL and high for MIC over 
1.0 kg/mL. 
Serotyping was done by the Quellung reaction, us- 
ing reagents from the Danish Statens Serum Institut 
(Copenhagen).*O 
RESULTS 
Two hundred and two children took part in this study: 
162 were HIV-negative (84 female; 78 male), and 40 were 
HIV-positive (23 female; 17 male). Of the HIV-negative 
children, 157 (97%) were younger than 3 years of age. All 
HIV-infected children were older than 39 months of age 
(range, 39-106 mo). 
Total nasopharyngeal S. pneumoniae colonization 
was 93 per 202 patients (46%): 50% and 30% for HIV- 
negative and HIV-positive children, respectively (Figure 1). 
Nasopharyngeal S. pneumoniae colonization was age- 
related in the HIV-negative children. The highest colo- 
nization rate (70%) was recorded between 4 and 12 
months of age. Nine of the 12 colonized HIV-infected 
children were over 5 years of age. 
Antibiotic susceptibility testing was performed on 
92 isolates. No significant differences were observed in 
the distribution of antibiotic resistance between the HIV- 
negative and HIV-infected children. The highest resistance 
rates were recorded against penicillin and TMP-SMX (99% 
each); 87% of the isolates were resistant to clindamycin 
or erythromycin. Two isolates were nonsusceptible to 
ceftriaxone (MIC 1.0 and 2.0 pg/mL, respectively). The 
cumulative MIC of penicillin and ceftriaxone for the 
nasopharyngeal S. pneumoniae are presented in Figure 
2. The MIC values of penicillin for the resistant isolates 
Age (mo) 
Figure 1. S. pneumoniae nasophatyngeal colonization by age group 
in 162 HIV-negative and 40 HIV-positive infants and children. 
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Figure 2. Cumulative MIC of penicillin and ceftriaxone for the 
nasopharyngeal S. pneumoniae isolates. 
ranged from 0.125 to I6 pg/mL. MI& and MIC,,of peni- 
cillin were 2.0 and 8.0 Fg/mL, respectively; 74% (GS/%!) 
of all isolates were highly resistant to penicillin (MIC >l .O 
pg/mL). MIC,, and MIC,, of ceftriaxone were 0.25 and 
0.5 pg/mL, respectively; 45% (41/92) of the S.pneu- 
moniae isolates had a MIC value of 0.5 y.g/mL for 
ceftriaxone. 
Typing was performed on 81 of 93 (87%) isolates: 
69 from HIV-negative and 12 from HIV-infected subjects. 
Overall the isolates belonged to six different serotypes 
(Figure 3). The most common (in order of decreasing fre- 
quency) were 23R 6A, and 19A. Serogroups 23,6, and 19 
together represented 97% of all isolates. No significant 
(2R, 
19A - 
(21%) (6%) 
Figure 3. Serotypes found in 81 of 93 nasopharyngeal S. pneumoniae 
isolates. 
difference in the distribution between HIV-infected and 
HIV-negative subjects was observed. 
The resistance patterns by serotype or group are pre- 
sented in Table 1. Eighty-nine percent (82/92) of the iso- 
lates were resistant to three or more drug categories, and 
40% (37/92) were resistant to five or more drug cate- 
gories. Sixteen (43%) of the S.pneumoniae isolates resis- 
tant to five-or more drug categories belonged to serotype 
19A. In all, 94% (16/17 isolates) of the serotype 19A S. 
pneumoniae were resistant to five or more drug cate- 
gories. AU serotype 19A S.pneumoniae were highly resis- 
tant to penicillin. MIC,, and MIC9, of these isolates were 
4 and 8 p,g/mL, respectively. 
Twenty-three percent of all isolates (types 19A, 11, 
and 29/34/35/42/47) were not covered by the currently 
available 7 to 11 valent antipneumococcal conjugate 
vaccines. 
DISCUSSION 
Antibiotic-resistant pneumococci have been reported in 
Romania since 1974, when Vata et al described four cases 
of meningitis due to resistant organisms in Iasi.‘l A 
marked increase in the frequency of resistant S. pneu- 
moniae has been reported in limited studies published 
from Romania.22-24 In a study investigating the nasopha- 
ryngeal carriage of resistant S. pneumoniae by children 
hospitalized or attending day-care centers or outpatient 
clinics in eastern and central Europe, the highest carriage 
rate (60.9%) was reported in Romania,z5 and in a recently 
completed study in eastern Europe, Spneumoniae were 
the most frequently recovered organisms from the middle 
ear fluid of children with acute otitis media and resistant 
S. pneumoniae represented 42% of the S. pneumoniae 
isolated from Romanian patients.26 However, these two 
studies have looked at only a limited number of isolates. 
The Romanian orphanage system for abandoned chil- 
dren became open to the Western world after the Decem- 
ber 1989 revolution, when an estimated 100,000 to 
300,000 children were found placed in “leagane” (insti- 
tutions taking care of children under 3 years of age), 
orphanages, and asylums for incurables.” Since 1989, it 
was discovered that more than 1700 institutionalized chil- 
dren in Romania are HIV-infected.28,29 
Most of them have acquired immunodeficiency syn- 
drome (AIDS) and live in orphanages separated from the 
other children cared for in these facilities. The prevalence 
of other infections in these orphanages is incompletely 
documented.30-3z 
This study documented that multidrug-resistant S. 
pneumoniae were highly prevalent in this orphanage in 
both HIV-negative and older HIV-infected children. Assum- 
ing a similarity between the carried isolates and those 
causing disease, this finding makes the empirical treat- 
ment of infections potentially caused by S.pneumoniae 
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Table 1. Resistance Patterns of Isolates to Various Antibiotics, according to S. pneumoniae Serotypes 
Number 
Resistance to Antibiotics Multidrug Resistance 
of Isolates PEN TMP/SMX ERY CL/N Tf?TR CHLOR CR0 3 or More 5 or More 
Serotype (n = 92) (99%) (99%) (87%) (87%) (48%) (21%) (2%) (89%) (40%) 
6A 22 100 100 100 100 52 0 0 100 36 
6B 5 100 100 100 100 100 0 0 100 100 
19A 17 100 100 94 94 100 100 0 100 94 
23F 35 100 97 74 74 14 3 0 74 11 
Others* 13 92 92 92 92 38 8 15 92 42 
*One serotype II isolate and one serotype 29/34/35/42/47; 11 were not typed, 
PEN = penicillin: TMP/SMX = trimethoprim-sulphamethoxazole; ERY = erythromycin; CLIN = clindamycin; TEAR = tetracyclin; CHLOR = chioramphenicol; 
CR0 = ceftriaxone. 
in this orphanage extremely problematic. The standard 
p-lactam antibiotic therapy for S,pneumoniae with inter- 
mediate resistance to penicillin was found to be effec- 
tive for nonmeningeal illnesses, although the 
cerebrospinal fluid (CSF) concentration of penicillin may 
be not adequate to eradicate the pathogen from the 
meninges.6 Because additional updated data on pneu- 
mococcal drug resistance in Romania are missing, it is 
not known whether these findings differ significantly 
from conditions in other communities and geographic 
areas in the country. However, the high prevalence of S. 
pneumoniae highly resistant to penicillin in this orphan- 
age may preclude the use of penicillin and possibly many 
other antibiotics, even in cases of nonmeningeal pneu- 
mococcal infections like bacteremia, pneumonia, acute 
otitis media, and sinusitis, and raises enormous public 
health concerns regarding the availability, cost, and appro- 
priateness of alternative antibiotic therapies for all pneu- 
mococcal diseases in Romania. 
Human immunodeficiency virus infection has been 
implicated as a risk factor for acquisition of invasive infec- 
tions due to resistant S. pneumoniae.33-36 However, the 
prevalence of colonization with resistant S. pneumoniae 
in HIV-infected patients and particularly in HIV-infected 
children has not been systematically studied. The fmding 
in this study, that a high prevalence of colonization with 
resistant Spneumoniae both in HIV-negative and in the 
older HIV-infected children, suggests that the high preva- 
lence of colonization and increased exposure to resistant 
Spneumoniae in the orphanage, rather than the HIV sta- 
tus, represent the major factors determining the carriage 
status of these children. On the other hand, the high rates 
of pneumococcal bacteremia among HIV-infected patients 
was found to be associated with low numbers of CD4+ T 
cells, and this impaired humoral responses to S.pneumo- 
niae rather than to increased exposure to the organism.33 
Resistant S. pneumoniae strains found in this study 
belonged to six serotypes or serogroups, the most com- 
mon being 23,6, and 19. The high prevalence of multi- 
drug resistant S. pneumoniae (coupled with high 
penicillin resistance) with a limited number of circulating 
serotypes stresses the need to further evaluate the con- 
jugate vaccines in children at risk for invasive S. pneu- 
moniae infection. Conjugate pneumococcal vaccine was 
found to significantly reduce the nasopharyngeal carriage 
of vaccine-type S.pneumoniae in infants and young chil- 
dren.37-39 However, the vaccine did not have any effect on 
the carriage of non-vaccine type S. pneumoniae, with 
the exception of serogroup GA. The fact that in 23% of 
Spneumoniae isolates in the orphanage the serotypes 
were not those covered by the currently studied 7 to 11 
valent conjugate anti-S. pneumoniae vaccines suggests 
that other serotypes of common antigens should be intro- 
duced and studied, to fight antibiotic resistance to S.pneu- 
moniae by effective vaccines. 
The extremely high incidence of resistant S. pneu- 
moniae and the multiple-drug resistance pattern of S. 
pneumoniae in the orphanage of Iasi emphasize the need 
for broader and continuous surveillance of the preva- 
lence and antimicrobial susceptibility profiles and 
serotype or serogroup distribution of S.pneumoniae in 
Romania, to better understand the evolution and spread 
of resistance all over the country and to guide patient 
therapy and development of effective vaccines. 
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